Publications

DSUVIA®

1. Primary Manuscript for SAP301
Minkowitz HS, Leiman D, Melson T, Singla N, Didonato KP, Palmer PP. Sufentanil sublingual tablet 30 mcg for the management of pain following abdominal surgery: a randomized, placebo-controlled, phase 3 study. Pain Pract. 2017;17(7):848-858.
6. DSUVIA: A Pooled Dosing and Efficacy Analysis Across Demographic Subgroups
Hutchins JL, Leiman D, Rafique Z, DiDonato KP, Palmer PP. Pooled dosing and efficacy analysis of the sufentanil sublingual tablet 30 mcg across demographic subgroups for the management of moderate-to-severe acute pain. J Perianesth Nurs. 2020;35(1):22-28.

ZALVISO®

ZALVISO is an investigational drug. It is not approved by the FDA. AcelRx makes no claims regarding the safety or effectiveness of ZALVISO.

2. Primary Manuscript for Phase 3 ZALVISO study IAP309
Melson TI, Boyer DL, Minkowitz HS, Turan A, Chiang YK, Evashenk MA, Palmer PP. Sufentanil sublingual tablet system vs. intravenous patient-controlled analgesia with morphine for postoperative pain control: a randomized, active-comparator trial. Pain Pract. 2014;14(8):679-688.
3. Primary Manuscript for Phase 3 ZALVISO study IAP310
Ringold FG, Minkowitz HS, Gan TJ, et al. Sufentanil sublingual tablet system for the management of postoperative pain following open abdominal surgery: a randomized, placebo-controlled study. Reg Anesth Pain Med. 2015;40(1):22-30.
4. Primary Manuscript for Phase 3 ZALVISO study IAP311
Jove M, Griffin DW, Minkowitz HS, Ben-David B, Evashenk MA, Palmer PP. Sufentanil sublingual tablet system for the management of postoperative pain after knee or hip arthroplasty: a randomized, placebo-controlled study. Anesthesiol. 2015;123(2):434-443.

Health Economics and Outcomes Research Articles

2. HEOR Study – Cost of IV Morphine in the EU
Casamayor M, DiDonato K, Hennebert M, Brazzi L, Prosen G. Administration of intravenous morphine for acute pain in the emergency department inflicts an economic burden in Europe. Drugs Context. 2018;7:212524.
3. HEOR Study – Cost of IV PCA
Palmer P, Ji X, Stephens J. Cost of opioid intravenous patient-controlled analgesia: results from a hospital database analysis and literature assessment. Clinicoecon Outcomes Res. 2014;6:311-318.